Clinical Trial Update: Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC [Phase 3]

View source ↗

Summary

Phase 3 trial comparing neoadjuvant versus adjuvant chemotherapy with docetaxel and carboplatin in early-stage Non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Chinese Society of Lung Cancer | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED